Shionogi antibiotic overcomes mortality concerns to win FDA panel’s support

Shionogi & Co. Ltd. (Tokyo:4507) said FDA’s Antimicrobial Drugs Advisory Committee on Wednesday recommended approving Fetroja cefiderocol to

Read the full 188 word article

User Sign In